XHKG
1332
, Last price
HKD
Name
China Touyun Tech Group Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.
Key people
Dong Du
Executive Director · since 2016
Yuen Wa Lo
Executive Director · since 2015
Ho Yee Poon
Managing Director, Executive Director · since 2012
Dixie Hui Sun
Executive Director · since 2014
Pui Yee Cheng
Company Secretary · since 2017
Liang Wang
Executive Chairman of the Board · since 2017
Hui Chen
Non-Executive Director · since 2016
Independent Non-Executive Director · since 2015
Independent Non-Executive Director · since 2014
Shing Chuen To
Independent Non-Executive Director · since 2014
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||